QualityStocks SUBMIT AN ARTICLE

JMAR Technologies is a late-stage technology company specializing in the development and early commercialization of detection and laser-based technologies for nano-scale imaging, chemical and biological analysis, and fabrication. The company’s two biggest product lines are the BioSentry system, a continuous, on-line, real-time monitoring system for detecting and classifying harmful micro-organisms in water; and the BriteLight laser, a diode pumped modular solid state laser product that produces soft x-rays through laser produced plasma.

The BriteLight laser product line is also used to provide laser sources for various applications, including spectrochemical analysis, nano-scale fabrication, microscopy, and soft x-ray source generation. JMAR also manufactures the DoublePulse laser, which is used by military and law enforcement personnel for remote detection of chemical, biological, radiological, nuclear, explosive (CBRNE) substances on roadsides, in military settings and at crime scenes. JMAR’s customers include governments, federal agencies such as Homeland Security, municipal utilities and pharmaceutical companies.

JMAR products are sold in the United States, Europe, Mexico, Asia, and Australia. Competitors include Coherent Inc., a division of defense giant Northrup Gruman, and closely held Renishaw Plc. Last month, JMAR said it signed four contracts worth a total of $750,000, which should help boost sales and help the company become profitable.

JMAR was founded in 1987 and has 16 employees. The company has a market capitalization of $9.14 million. Shares closed Monday at 16 cents and have traded between 4 cents and 28 cents over the past 52 weeks. Insiders own about 18 percent of JMAR shares and four institutions own more than 90,000 shares between them.

Let us hear your thoughts below: